Harbor Capital Advisors, Inc. Haemonetics Corp Transaction History
Harbor Capital Advisors, Inc.
- $2.3 Billion
- Q3 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 56,164 shares of HAE stock, worth $4.97 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
56,164
Previous 25,775
117.9%
Holding current value
$4.97 Million
Previous $2.13 Million
111.73%
% of portfolio
0.2%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$528 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$458 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$393 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$372 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$357 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.54B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...